Laboratory Assessment of Novel Oral Anticoagulants: Method Suitability and Variability between Coagulation Laboratories | Zendy

Tuukka Helin | Zendy; Anja Pakkanen | Zendy; Riitta Lassila | Zendy; Lotta JoutsiKorhonen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Laboratory Assessment of Novel Oral Anticoagulants: Method Suitability and Variability between Coagulation Laboratories

Author(s) -

Tuukka Helin,

Anja Pakkanen,

Riitta Lassila,

Lotta JoutsiKorhonen

Publication year - 2013

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2012.198788

Subject(s) - rivaroxaban , partial thromboplastin time , dabigatran , prothrombin time , coagulation testing , medicine , thromboplastin , coagulation , thrombin time , apixaban , chromatography , chemistry , warfarin , atrial fibrillation

Laboratory tests to assess novel oral anticoagulants (NOACs) are under evaluation. Routine monitoring is unnecessary, but under special circumstances bioactivity assessment becomes crucial. We analyzed the effects of NOACs on coagulation tests and the availability of specific assays at different laboratories.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research